Ana Sofia Matias, Raquel Vinhas, Rita Mendes, Alexandra R. Fernandes, *Pedro Viana Baptista
UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, Caparica, Portugal.
*Correspondence to email@example.com
Disclosure: The authors have declared no conflicts of interest.
Acknowledgements: This work was partially supported by FCT/MEC to Unidade de Ciências Biomoleculares Aplicadas by national funds from (UID/Multi/04378/2013) and co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728); PD/BD/52211/2013 for RV; PTDC/QEQ-MED/1902/2014 for RM.
Received: 07.08.17 Accepted: 16.11.17
Citation: EMJ Innov. 2018;2:80-87.
Nanotechnology has become an important approach to improving the diagnosis and treatment of cancer; advances in this area have made it possible to use various materials to detect cancers in the early stages. Materials at the nanoscale have unique physical, optical, and electrical properties that are useful for cancer detection. Nanoparticles, alongside the discovery of several biomarkers, made it possible to reduce the detection limit of cancer biomarkers and this breakthrough provided the possibility of new methodologies for diagnosis with simple and non-invasive approaches. Haematological malignancies such as leukaemia and lymphoma represent a specific class of cancer that attract special attention in this area of diagnoses. The aim of this review is to elucidate the applications of nanotechnology for these types of cancer and the potentialities of nanotechnology for the diagnosis of haematological malignancies. When combined onto a single nanomaterial (an approach known as nanotheranostics), these platforms may revolutionise the way we tackle liquid tumours, as well as providing innovative tools for precision oncology, diagnostics, and follow-up therapy and disease management.
This article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
The post Nanoparticles as Emerging Diagnostic Tools in Liquid Tumours appeared first on European Medical Journal.